Chapter 10: Skin Pathology

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace, the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today, we are doing something that sounds almost impossible on paper.

Slight chuckle.

Just a little bit.

We're taking a stack of notes that, let's be honest, strikes fear into the hearts of medical students.

We're talking pathology, and we're going to try to turn it into something that isn't just memorable, but actually, well, visible.

Which is a bit of a paradox, isn't it?

Yeah.

For an audio format.

But if you really think about it, it makes perfect sense.

Completely.

But that's the challenge we've set for ourselves.

We're taking a guided tour through the body's largest organ.

We're talking about the skin.

And specifically, we're breaking down chapter 10 of the USMLE Step One Pathology Lecture Notes from 2017.

And this isn't just about memorizing lists of diseases.

Our mission here is to take these diagrams, these microscopic descriptions, and these clinical photos from the text,

and really translate them into a kind of mental roadmap.

Because in so much of medicine, we're relying on these high -tech scan CTs, MRIs, to see what's going wrong deep inside the body.

But with skin,

the pathology is right there.

It's literally staring back at you.

It's the only organ where you can effectively diagnose a genetic mutation from across the room if you know what patterns to look for.

Exactly.

Dermatology and skin pathology are fundamentally exercises in pattern recognition.

You see a change in color or a bump or a blister on the surface.

That's what we call the gross morphology.

What you see with your eyes.

What you see with your eyes.

And you have to instantly correlate that with what's happening to the cells underneath, the microscopic morphology, to connect the macro to the micro.

So to keep us on track, let's outline our roadmap for this deep dive.

We are sticking strictly to the text provided to us following the chapter right in order.

Good idea.

We're going to start with section one, disorders of pigmentation.

This is really about the basic question.

Why does skin lose color?

Or on the flip side, why does it gain color?

From there, we move into section two, melanocytic tumors.

And that's

ranging from your totally benign moles, which I mean almost everyone has, all the way to malignant melanoma.

The scary stuff.

Then section three is a massive one.

It's the epidermal and dermal lesions.

This is our grand tour of rashes, blisters, autoimmune wars happening in the skin layers, the bumps and lumps, so to speak.

A big category.

It is.

And finally, we wrap up with section four, the other skin cancers.

These are the that aren't melanoma, specifically squamous cell and basal cell carcinomas.

The two most common ones by far.

By the end of this hour, we want you to be able to visualize keratin pearls and palisading nuclei as clearly as if you were looking down a microscope yourself.

Before we dive in, I think it's worth just pausing on why this matters so much.

Skin pathology is unique because it's all about connecting a gene mutation, this tiny invisible molecular change to a visible lesion.

It's like investigating the scene without even having to open the door.

I love that analogy.

OK, let's unpack this.

Section one, disorders of pigmentation.

We are started with the concept of color.

Skin color is essentially a product of a factory, right?

That is a great way to think about it.

The factory workers are the melanocytes.

These are specialized cells that live at the bottom layer of your epidermis, the basal layer.

OK.

And their entire job, their whole purpose is to produce one product,

melanin.

That's the pigment.

It's what gives skin its color and, just as importantly, protects us from UV radiation from the sun.

So when we look at pathology in this section, we're basically asking, are the factory workers missing?

Are they, I don't know, lazy or are they working way too hard?

Precisely.

It's a problem of production one way or the other.

So let's start with something that is just visually so striking, vitiligo.

Vitiligo is a classic starting point.

In the text, we have figure 10 -2, which shows the hands of a patient.

And if you're listening, I really want you to visualize this.

You have the person's normal skin tone.

Let's say it's a darker skin tone.

And then you have these very distinct irregular patches that are completely white.

And when we say white, we don't just mean pale.

We mean fully depigmented, like chalk white.

Completely depigmented.

That is the crucial distinction.

It's not a fading.

It's an absence of color.

And it creates this sharp, almost map like pattern on the skin.

The text notes, this is common.

It can affect any race.

It's not specific to one demographic.

So what is actually happening here?

Why does the color just vanish in these specific patches?

Is the factory broken?

It's worse than broken.

The workers are gone.

The etiology, or the cause, is technically listed as unknown in the notes.

But the text points us very, very strongly toward an autoimmune mechanism.

The body attacking itself.

The prevailing theory is that the body's immune system just decides that melanocytes are the enemy.

It launches a targeted attack and eliminates them.

So if we took a biopsy of that white patch of skin and put it under a microscope, what would we see?

Or what wouldn't we see?

That's the better question.

You wouldn't see any melanocytes.

In those white patches, the epidonal melanocytes are completely absent.

They're not just sleeping on the job.

They're not just failing to produce pigment.

They have been utterly destroyed and removed from that area of skin.

Wow.

Okay.

So vitiligo is the absence of the factory workers?

They've been laid off permanently.

Now, let's flip the switch.

Let's go to the other extreme.

Too much pigment.

The text brings up melasma.

Right.

Melasma is visually quite different.

Instead of those stark white patches, what you see are irregular, blotchy patches of hyperpigmentation.

So darkening of the skin.

Not a mole, just a patch.

Just a patch, exactly.

And the location is really key here.

It's typically on the face.

You'll see it on the cheeks, the forehead, the upper lip.

It has a very characteristic distribution.

And there are some very specific associations with melasma, right?

I've heard it called the mask of pregnancy.

That's the classic moniker.

It is strongly, strongly associated with pregnancy, but also with oral contraceptive use.

So there's very clear hormonal component.

It seems that high estrogen states, for whatever reason,

drive the melanocytes to overproduce pigment in these specific hormonally sensitive areas of the face.

So in this case, the workers are all there, but the hormones are basically screaming at them to work harder.

Exactly.

And the text also notes it's associated with sun exposure, which kind of acts as a secondary stimulant that makes it worse.

But the good news, as the notes point out, is that it may regress.

Once the pregnancy is over, or you stop the oral contraceptives, the mask often fades on its own.

Okay.

So we've got vitiligo loss of cells and melasma hormonal darkening.

Now I want to challenge you on the next two, because to me, and probably to a lot of people just looking in the mirror, these look really similar.

We're talking about freckles and benign lintigo.

This is a classic board exam distinction, and you're right, a great point of confusion.

Macroscopically, to the naked eye, yes, they are both small brown macules.

A macule just means a flat spot on the skin.

Right.

But biologically, they're doing two very different things at the cellular level.

Okay.

Let's start with freckles.

The scientific name in the text is

right.

Ethilis, singular, ethylates, plural.

Yes.

These are the classic spots you see on fair skin children.

On the face, shoulders, chest.

The hallmark behavior of a freckle is that it's dynamic.

It reacts to the environment.

Meaning they change with the seasons, they pop out in the summer.

Exactly.

They darken with sunlight exposure, and then they fade in the winter when there's less sun.

Now the million dollar question is what's happening under the microscope.

Well, based on our factory analogy, do we have more workers, more melanocytes?

No.

Yeah.

And that's the key.

In a freckle, you have a normal number of melanocytes.

But because of the sun excosure, those workers are pulling double shifts.

There's just an increased amount of melanin deposition in the basal layer.

The factory is overproducing.

So freckle equals the same number of workers, but they are cranking out more product because the sun is telling them to.

You've got it.

Now compare that to the benign lentigo.

These are also small oval, light brown macules.

But unlike freckles, they don't have that dramatic fade and darken cycle with the seasons.

They tend to stick around.

And the reason for that lies in the microscope.

It does.

In a benign lentigo, you have a localized proliferation of melanocytes.

The text describes it as linear melanocytic hyperplasia.

Hyperplasia.

That word means an increase in the number of cells.

Correct.

So in this case, you literally have more factory workers showing up.

They're lining up along the basement membrane.

It's an increase in cell count in that localized spot.

So that is the hook.

Freckle equals more pigment, same number of cells.

Lentigo equals more cells.

Simple, but absolutely critical for understanding the pathology.

One is a functional issue.

The other is a growth issue.

That makes a lot of sense.

All right, let's move on to section two.

We're getting into melanocytic tumors.

And we should probably clarify here when we say tumor in pathology, we don't always mean cancer.

Right.

That's a huge misconception.

Tumor, in the strictest sense, just implies a swelling or a mass.

It can be totally benign.

And in this section, we're looking at the entire spectrum, from completely benign moles to malignant melanoma.

So let's start with the harmless stuff.

The nevi, or as normal people call them, moles.

We can start with congenital nevi.

As the name implies, these are the birthmarks that are present right from the beginning.

Most are harmless.

They're just part of who you are.

But the text does flag a specific risk factor here.

Which is?

Giant congenital nevi.

If a baby is born with a very, very large nevis, one that covers a significant surface area of their body, there's an increased risk of that lesion transforming into melanoma later in life.

Okay, so size really matters for the congenital ones.

What about the common mole, the one you might develop in your childhood or your 20s?

That is the nevicellular nevis.

By definition, it's a benign tumor of melanocytes.

The text notes that these are clearly related to sun exposure.

The more sun you get, typically the more moles you develop.

And visually.

What makes a mole boring and therefore good?

Boring is definitely good in dermatology.

You're looking for uniformity.

A uniform tan to brown color.

Sharp, well circumscribed borders.

It should be stable in its shape, stable in its size.

No surprises.

We like stable.

Now I see there are subtypes listed here in the notes.

Junctional, compound, and intradermal.

What does that mean?

Is it important?

It is because it refers to where the nest of melanocytes is sitting within the skin layers.

And it's actually a progression, a life cycle of the common mole.

It's not static.

Oh, interesting.

So it evolves.

It does.

You start with a junctional nevus.

Junctional, okay.

Meaning the nest of melanocytes cells is right at the junction of the epidermis and the dermis.

They're sitting right on that fence.

These tend to be flat and dark.

Okay, that's stage one.

Then what happens?

Then over time, it can become a compound nevus.

The cells start to migrate down into the dermis.

So now you have nests of cells at the junction and nests growing down into the dermis.

These moles are often slightly raised.

And the final stage of this life cycle is the intradermal nevus.

At this point, the junctional component disappears entirely.

All the nests of cells are now completely within the dermis.

These are the soft, fleshy, raised bumps that often lose their pigment and become skin -colored over time.

It's like they're slowly sinking deeper into the skin as the mole matures and gets older.

That's a perfect way to visualize it.

And this migration downwards and loss of pigment is actually a sign of benign maturation.

We call it neurotization.

It's a good thing.

Okay, so that's the common boring good mole.

But now we have to talk about the troublemaker.

The dysplastic nevus.

The text also calls these BK moles.

Dysplastic nevus are the warning signs.

They're the ugly ducklings on the skin.

Visually, they break all the rules of the common mole.

How so?

Well, for one, they're typically larger, usually greater than six millimeters.

They have irregular, fuzzy, or notched borders.

And the color is often described as variegated.

Variegated meaning like multiple shades.

Exactly.

It's not just one uniform shade of brown.

It's a mix of dark brown, some light brown, maybe some pink or reddish hues mixed in.

It just looks messy,

disorganized.

And I assume under the microscope, it also looks disorganized.

It does.

It shows what we call atypia.

Both cytological atypia, meaning the cells themselves look a bit funny, and architectural epipia, meaning the way they're arranged is disorganized.

They aren't cancerous yet, but they're definitely not normal.

And there's a serious genetic component here too, right?

This isn't just about sun exposure.

This is where it gets really interesting, especially for anyone studying for their board exams.

There is a condition called dysplastic nevus syndrome.

And it's an autosomal dominant disorder.

The text links it specifically to the CMM1 locus on chromosome 1.

Chromosome 1.

Okay.

I'm noting that down.

Patients with this syndrome often have hundreds of these dysplastic nevus.

And the implication is very serious.

They have a significantly increased risk.

We're talking close to 100 % lifetime risk of developing melanoma.

And importantly, the melanoma doesn't just come from one of the existing moles.

It can arise from normal looking skin too.

The whole system is just genetically unstable.

Which brings us then to the big one, malignant melanoma.

The text says the incidence is increasing at a really rapid rate.

It is.

It's a true malignancy of the melanocytes themselves.

The peak age is around 40 to 70.

And the risk factors are pretty much what you'd expect.

Chronic sun exposure and especially severe blistering sunburns in childhood.

Also fair skin and a family history.

Let's do a deep dive into the genetics here.

We mentioned chromosome 1 for the benign dysplastic nevus syndrome.

What about melanoma itself?

So for familial melanoma, where it clearly runs in families, we're looking at a loss of function mutation in a crucial tumor suppressor gene.

Specifically, the P16 gene, which is also known as CDKN2A.

And where does that gene live?

Which chromosome?

That one is on chromosome 9.

So dysplastic nevus syndrome is chromosome 1.

Familial melanoma of the P16 gene is on chromosome 9.

That is a very high yield distinction to remember.

Got it.

And the text also mentions some other somatic mutations.

Things that aren't inherited.

Yes.

These are mutations that happen in the tumor cells themselves during a person's life.

The two big ones mentioned are BRAF and NRAS.

BRAF is particularly important in modern medicine because we now have targeted therapies for it, although the text here is focusing more on the basic pathology.

Okay.

Now for the listener who might be checking their own skin right now, let's talk about visual identification.

We always hear about the ABCDs.

Right.

And they're incredibly useful.

The text lays them out.

A is for asymmetry.

If you draw a line down the middle and fold the lesion in half, the two sides don't match.

B is for borders.

They're irregular, notched, or seem to be leaking pigment into the surrounding skin.

C is for color.

Variegated.

A mix of black, brown, red, white, or even blue.

And D is for diameter.

Usually larger than 6 millimeters, which is roughly the size of a pencil eraser.

And the text references figure 10 -3, which shows this perfectly.

It's not a nice round brown dot.

It's a sprawling, messy, multicolored patch that just looks angry.

It does.

And then figure 10 -4 shows the microscopy.

Remember the neat, orderly nests of cells we saw in benign moles?

In melanoma, those nests are chaotic.

They're large, irregular, they're fusing together, and they're invading tissues where they just shouldn't be.

The text also notes some interesting location patterns based on gender.

It does.

This is a classic epidemiologic finding.

For males, the most common site to develop melanoma is the upper back.

For females, it's the back and the legs.

So keep an eye on those calves.

Now, not all melanomas are the same.

We have four major subtypes listed here.

Let's break them down.

Okay.

First is lentigo maligna.

This is the one you typically see on the face or neck of older people areas with a lifetime of chronic sun damage.

The key here is that it stays in the top layer of skin, the epidermis, for a very long time.

It grows radially or horizontally.

So it spreads out before it goes down.

Exactly.

And because it doesn't dive deep quickly, it has the best prognosis of the four types.

Okay.

So horizontal growth is good.

Vertical growth is bad.

What's next?

Next is superficial spreading melanoma.

This is the most common type overall.

And as the name suggests, it also has a prolonged horizontal or superficial spreading phase before it eventually decides to invade deep.

And the third one is really interesting because we often think of melanoma as a disease of fair skinned people who get too much sun.

But this one kind of breaks that rule.

It really does.

This is a crawl antigenous melanoma.

A crawl refers to the extremities.

So this appears on the palms of the hands, the soles of the feet, or in subungual locations, meaning under the fingernails or toenails.

And the significance.

This is the most common subtype in dark skinned individuals.

And crucially, it is not related to UV exposure.

That is a huge myth buster.

You can get melanoma where the sun doesn't shine.

And finally, the really bad actor of the group.

That would be nodular melanoma.

This one is so dangerous because it pretty much skips the horizontal growth phase.

It doesn't waste time spreading out.

It goes straight for vertical growth from the very beginning.

It just dives deep.

It dives deep immediately.

It presents as a raised, often blue -black nodule.

Yeah.

And because of that aggressive vertical growth, it has the worst prognosis.

Speaking of prognosis, how do we stage this?

What's the most important factor?

We use the TNM staging system.

But the single most important prognostic factor, the number one predictor of survival, is the Braselot thickness.

What is that exactly?

How do you measure it?

It is a physical measurement that the pathologist makes with a ruler under the microscope.

They measure the depth of invasion in millimeters from the granular layer of the epidermis all the way down to the deepest identifiable tumor cell.

So the deeper it has managed to go, the worse the outlook.

Exactly.

Because once it gets into the deeper dermis, it gains access to blood vessels and lymphatics.

And that's the superhighway to the rest of the body for metastasis.

And the treatment.

For local disease, it's wide surgical excision.

You want to cut it out with a significant safety margin of normal skin around it.

You might do a sentinel lymph node biopsy to see if it has already spread to the local lymph nodes.

And if it has spread?

If it's gone systemic, then we're looking at chemotherapy, or more commonly now, immunotherapy.

But the text adds a really scary fact at the end of this section.

Metastasis can occur after years and years of dormancy.

That is chilling.

It implies the cells can just go to sleep somewhere in the body.

They can.

They can hide out in the liver or the brain for 5, 10, even 15 years.

You think you're in the clear, and then it comes back.

That's why long -term follow -up is absolutely non -negotiable for melanoma patients.

Okay, that's a lot to take in.

Let's shift gears.

We're leaving the world of pigmentation and moles and moving into section 3, epidermal and dermal lesions.

This is the big bumps and rashes tour.

It is.

This is a bit of a grab bag of very common, and thankfully, very distinguishable conditions.

It's really where dermatology starts to overlap heavily with internal medicine.

And let's start with one that I think is a perfect example of skin reflecting internal health.

Acanthosis nigricans.

Yes.

Visually, this is thickened hyperpigmented skin.

It's often described as having a velvety texture.

You typically see it in skin folds, like the posterior neck, the back of the neck or in the armpits, the axillae, and the groin.

And if you see this, what should you be thinking?

What should you be worried about?

Well, the most common association by far is obesity and hyperinsulinism.

It's a classic skin sign of insulin resistance or full -blown type 2 diabetes.

The high levels of insulin in the blood actually act as a growth factor and stimulate the skin cells to proliferate.

But there is a rarer, much more sinister association, right?

There is, and you have to know this.

Rarely, especially if it appears suddenly and rapidly in a non -obese older person, it can be a perineoplastic sign of an internal malignancy.

A sign of cancer somewhere else.

Exactly.

Specifically gastrointestinal cancers, like stomach cancer.

So a velvety neck isn't always just about blood sugar.

You have to consider the context.

Next up, we have something that I feel like every grandparent has.

Saboraic keratosis.

Ah, chuckles.

These are incredibly common in middle -aged and elderly people.

We sometimes call them the barnacles of aging.

They just sort of accumulate over time.

Describe the look for us.

They are tan to brown coin -shaped plaques.

They have a greasy or granular surface.

But the key phrase in the text, and you will see this on exams over and over, is a stuck -on appearance.

Stuck on?

Yeah, that literally is like someone took a piece of brown wax or chewed up gum and just stuck it onto the person's skin.

It doesn't look like it grew out of the skin.

And what's happening under the microscope?

You see what's called basaloid epidermal hyperplasia, but the absolute giveaway feature is the presence of horn cysts.

What exactly is a horn cyst?

It's a little circular collection of keratin, the main skin protein, that gets trapped inside the tumor as it grows.

It looks like a little swirl or pearl of pink keratin embedded within lesion.

Is it dangerous?

Generally no.

They are completely benign.

But just like with acanthocyst nigricans, there is a very specific perineoplastic sign to watch for.

It's called the sign of lazartrelat.

Okay, what happens there?

This is when a patient suddenly develops dozens, even hundreds, of sevrate keratosis, like a swarm of them erupting all at once.

That sudden eruption can signal an internal malignancy, again often a GI carcinoma like stomach or colon cancer.

The skin is just waving a huge red flag for the internal organs.

Okay, now let's talk about psoriasis.

This affects about one to two percent of the population, so it's quite common.

Psoriasis is a chronic autoimmune disorder.

The core mechanism is a massive increase in the proliferation and turnover of skin cells, the keratinocytes.

The factory is running it like 10 times the normal speed.

How fast is that?

Normally, your skin cells take about a month to mature and travel from the basal layer to the surface to be shed.

In psoriasis, they do it in just a few days.

And what does that look like visually?

What does that build up create?

It creates these very well demarcated erythematous or red plaques that are covered with a very characteristic silvery scale.

That silver scale is literally the buildup of all those extra skin cells that were rushed to the surface and haven't shed properly.

And we have a figure for this, figure 10 to 5.

It shows these plaques on the knees and elbows, which are classic sites.

The text also mentions the scalp and the gluteal cleft.

Right.

And there is a specific physical exam finding you can elicit called the Auspitz sign.

If you take a glass slide and you scrape off that silvery scale, you'll see pinpoint bleeding underneath.

Why does it bleed?

What's going on there?

To understand that, you have to visualize the microscopy.

In psoriasis, the epidermis as a whole thickens.

We call that acanthesis.

But the little fingers of the dermis, the dermal papate that push up into the epidermis get very long and swollen with dilated blood vessels.

OK.

And critically, the layer of epidermis right on top of those swollen fingers gets very, very thin.

And those dermal fingers contain the blood vessels.

Precisely.

So when you rip the scale off, you're essentially ripping the thin roof off those dilated superficial blood vessels, hence the pinpoint bleeding.

That makes sense.

Speaking of microscopy, there's some other buzzwords here that we need to know.

Absolutely.

You see paracrytosis.

This means the cells in the very top layer, the stratum corneum, still have their nuclei.

Normally they should be gone.

But the cells were rushed to the surface so fast they didn't have time to fully mature and lose their nucleus.

A sign of rapid turnover.

Exactly.

And you also see Monroe micro abscesses, which are little collections of neutrophils that get trapped in that paracrytotic layer.

They look like little specks of inflammatory cells in the stratum corneum.

And psoriasis isn't just skin deep, is it?

The text mentions it's associated with arthritis.

Yes.

Psoriatic arthritis is a major association.

But also myopathy and aneropathy.

It's a true systemic inflammatory condition.

All right, brace yourselves, listeners.

We are now entering the blistering diseases.

This is often a huge point of confusion for students because the names sound so similar.

Pemphigus vulgaris versus bullis pemphigoid.

This is the battle of the belay.

You absolutely have to keep these straight.

The best way to do it is to start with the basic anatomy.

What holds our skin cells together?

Well, you have connections between the cells themselves, and then you have connections that anchor the whole sheet of cells to the floor, to the dermis below.

Perfect.

The connection between individual cells is the desmosome.

And the connection that anchors the bottom layer of cells to the floor, the basement membrane, is the hemidesmosome.

OK.

So desmosome is like a handshake between cells.

Hemidesmosome is like having your shoes glued to the floor.

That is a perfect analogy.

Now let's look at Pemphigus vulgaris.

This is a rare but potentially fatal autoimmune disorder.

The target here, the thing the antibodies attack, is desmoglane 3.

And desmoglane is a protein that's part of the desmosome, part of the handshake.

Exactly.

So the antibodies attack the handshakes, the cells fall apart from each other, and this happens inside the epidermis.

So we call this an intraepidermal blister.

So the blister forms within the layers of skin.

What does that blister look like clinically?

Because the roof of the blister is very thin, it's just a few layers of epidermal cells.

The blisters are flaccid, they're soft, they're saggy, and they rupture very, very easily.

You often just see raw, open sores and erosions rather than intact bubbles.

And there's another key feature.

Yes, it often involves the mouth.

Oral lesions are very common and are often the first sign.

Okay, and the microscopic look.

You see acantholysis, which is the fancy word for loss of adhesion.

The cells are just floating apart from each other.

But notice,

the very bottom layer of cells, the basal layer, is still attached to the floor because the hemismosomes are fine.

This leaves a very characteristic tombstone arrangement of the basal cells.

Like a row of tombstones along the floor of the blister.

Creepy, but memorable.

And the immunofluorescence, that's the special stain we use.

You stain for the antibodies, you see a glowing outline around every single cell because the target protein is on the surface between the cells.

It creates a beautiful but deadly net -like pattern of IgG deposits.

Okay, so pemphigus equals desmoglane, intrapodermal, flaccid blisters,

tombstones, and a net -like pattern.

Now let's look at its rival, bullous pemphigoid.

Bullous pemphigoid is more common, and it typically affects older individuals.

The target here is completely different.

The antibodies attack bullous pemphigoid antigens 1 and 2, and these are part of the hemidismosome.

So we are attacking the shoes.

We are ungluing the entire sheet of skin from the floor.

So the split, the blister happens under the whole epidermis.

It is a subepidermal blister.

Which means the roof of the blister is the entire thickness of the epidermis.

Yes, and that makes the blister incredibly strong.

Clinically, these are tense belay.

They don't rupture easily.

You can poke them and they stay intact.

And importantly, the oral mucosa is usually spared.

And the immunofluorescence pattern.

Instead of that net -like pattern, you see linear deposits of IgG right along the dermal junction.

It looks like a single, sharp, blowing straight line.

So bullous pemphigoid equals hemidismosome, subepidermal, tense blisters, and a linear pattern.

That is a crucial distinction to have locked down.

Absolutely.

If you know the target, everything else follows logically.

Let's hit a few more blistering conditions mentioned in the text.

Dermatitis herpetiformis.

This one is fascinating because it is a skin manifestation of a gut problem.

It is strongly associated with celiac sprue.

So a gluten allergy causes a rash.

Essentially, yes.

In people with celiac disease, IgA antibodies develop against glyadin, which is a component of gluten.

For some reason, these antibodies cross -react and deposit at the very tips of the dermal pepillate in the skin.

And what does that look like visually?

It causes intensely itchy, grouped vesicles.

We call them herpetiformis.

Not because it's related to the herpes virus, but because the clusters of little blisters look like a herpes outbreak.

You typically see them on the extensor surfaces, elbows, knees, buttocks.

And the treatment, then, isn't a cream.

It's a diet.

A strict gluten -free diet often clears the skin completely.

One more in this category.

Porphyria cutinia tarda.

This is a disorder of haem synthesis, the molecule that carries iron in our blood.

It can be familial or acquired.

The key clinical feature is blistering on the upper extremities, specifically the backs of the hands.

That happens secondary to sun exposure or even minor trauma.

Ah, the vampire disease.

Blistering in the sun.

In a way, yes.

Microscopically, it involves subepidermal blisters, and you see thickened dermal vessels.

Okay, let's move on from the blisters to the dry and itchy category.

We have ichthyosis vulgaris.

This is an inherited disorder.

The skin looks like fish scales, hence the name ichthyosis.

The text notes the key microscopic features are a thickened stratum corneum, but importantly, an absent stratum granulosum.

And xerosis.

That's simply the medical term for dry skin.

It is very common in the elderly, due to a decrease in the natural lipids in the skin barrier.

The text also notes it can be a significant side effect of EGFR inhibitor drugs used in cancer treatment.

Now, eczema.

This is a huge, huge bucket of a term.

It is.

Eczema, or dermatitis, is a pattern of reaction.

The key microscopic feature is spongiosis, which is edema or fluid accumulation between the skin cells, pushing them apart.

The text mentions atopic dermatitis specifically.

Yes.

This is the classic eczema we see in kids.

It's part of the allergic, or atopic, triad.

Asthma, allergic rhinitis, and atopic dermatitis.

And we now have a specific gene identified.

Mutations in the filigrine gene, FLG.

What does filigrine do?

It's a crucial protein for maintaining the skin barrier.

If it's mutated or deficient, the barrier becomes leaky.

Moisture gets out, which makes the skin dry, and allergens and irritants can get in, which causes inflammation.

And contact dermatitis.

That's strictly an environmental reaction.

It can be allergic, like poison ivy, which is a classic type IV hypersensitivity reaction.

Or it can be something like photodermatitis, where a drug you're taking interacts with sunlight to cause a rash.

We have a bit of a rapid fire section here at the end of section three.

I'm just going to throw a condition at you.

You give me the high yield headline from the text.

Right, let's do it.

Ferrucchi.

Warts, caused by HPV, the human papillomavirus.

Ferrucchi vulgaris is the most common type, the common wart.

Cutaneous lupus.

Autoimmune.

Can be acute, which is the classic butterfly rash on the face.

Subacute or chronic, which causes discoid plaques that scar.

The diagnostic feature is IgG and complement deposition at the epidermal junction on immunofluorescence.

Arithema multiform.

A hypersensitivity reaction.

The key visual is targetoid lesions.

They look like a target or a bullseye.

The triggers are crucial.

Infections, especially herpes simplex or mycoplasma.

Drugs like penicillin or sulfonamides.

And the scary version of that.

Is Stevens -Johnson syndrome or SJS.

That's when it gets severe and involves the mucous membranes, the eyes, mouth, genitals.

It's a true medical emergency.

Deterious dysrosia.

This has a classic progression.

It starts with a herald patch.

One single oval scaly lesion.

Then a week or two later, a widespread eruption occurs in a Christmas tree pattern on the trunk.

It's self -limiting, goes away on its own.

Granuloma annulare.

Chronic papules and plaques, often in a ring shape.

Under the microscope, you see palisaded granulomas.

Usually seen in healthy patients.

Erythema nodosum.

Painful, red, deep nodules.

The key location is the anterior shins.

This is a peniculitis, an inflammation of the subcutaneous fat and is often associated with a strep infection or granulomatous diseases like sarcoidosis.

And finally, epidermoid cyst.

A very common benign cyst.

It's essentially a pouch filled with keratin debris.

It smells absolutely terrible if you rupture it, but it's totally harmless.

You nailed it.

That brings us to our final section, section four, malignant tumors, non -melanoma.

We've already done melanoma, now we need to cover the other guys.

Right.

And these are actually much, much more common than melanoma, but generally much less deadly.

We are talking about squamous cell carcinoma, or SEC, and basal cell carcinoma, or BCC.

Let's start with squamous cell carcinoma.

SEC arises from the keratinocytes, the main squamous cells of the epidermis.

The peak incidence is around age 60.

And the risk factors here are huge.

Chronic UVB sun exposure is number one, but also things like arsenic exposure, radiation, and immunosuppression, for example, in organ transplant patients.

And the genetics.

The text notes that TP53 mutations and HRAS mutations are very common in these tumors.

And SEC doesn't just appear out of nowhere.

We have precursors.

Right.

You often see a precursor lesion called ectinoceratosis.

These are those rough, red, sandpaper -like papules you feel on sun -exposed skin, like the scalp of a bald man.

That is dysplasia.

If that progresses to a full -thickness carcinoma that hasn't invaded yet, carcinoma in situ,

it's called Bowen disease.

And what does the actual invasive cancer look like?

It's usually a tan, nodular mass, often ulcerated or crusted.

You typically see it on face, the lower lip, or the backs of the hands.

The microscope features for SEC are classic.

The text points to figure 10 to 7.

Absolutely classic.

You have to look for two things.

First, keratin pearls.

The tumor cells are still trying to do their job, which is making keratin, but they're doing it badly and in the wrong place.

They form these beautiful concentric swirls of pink keratin deep in the dermis.

It looks like an onion made of keratin.

And the second thing.

Intercellular bridges.

These are the desmosomes, the handshakes, connecting the individual cancer cells.

Under high power, you can see these little spiny bridges between the cells, which you see bridges and pearls.

You're looking at SEC.

And the prognosis?

Generally good.

It rarely metastasizes.

A simple surgical excision is usually curative.

There is a variant mentioned here called a keratococanthoma.

What is that?

This is a weird one.

It's a tumor that grows incredibly fast.

It'll be a rapidly growing dome -sheep nodule with a central keratin -filled crater.

It looks terrifying,

but then it can spontaneously regress and just go away on its own.

It's considered a very well -differentiated variant of SEC.

And finally, the single most common tumor in adults in the Western world.

Basal cell carcinoma.

BCC.

It arises from the basal cells of the hair follicles.

And again, sun exposure on fair skin is the number one driver.

What is the classic exam description?

If I'm reading a case file, what are the buzzwords I'm looking for?

You are looking for a pearly papule.

It has a shiny translucent, almost pearly quality to it.

It often has telangiectasis, which are tiny visible blood vessels running over its surface.

And if it ulcerates, it's historically called a rodent ulcer because it has heaped up rolled borders and a central ulceration that looks like a rat has chewed out the center.

That is a graphic description.

And microscopically, the text has figure 10 to 8.

You see invasive nests of these very basaloid cells are very blue and have small dark nuclei.

And the absolute key pattern to recognize is palisading.

The cells at the very edge of the tumor nests line up parallel to each other, like a picket fence or a stockade wall.

It's very orderly at the periphery.

And the genetics for BCC.

It's all about mutations in the hedgehog signaling pathway.

What about its behavior?

How dangerous is it?

It is locally aggressive.

It will chew through skin, cartilage, even bone, if you let it go unchecked.

Hence the rodent ulcer name.

But, and this is a huge, but it almost never metastasizes.

It stays local.

So to summarize the big two,

SCC creates pearls and bridges.

BCC creates palisades and pearly papules.

You got it.

Those are the key takeaways.

We have covered a massive amount of ground today.

I mean from the white patches of vitiligo all the way to the pearly papules of basal cell carcinoma.

We really did.

We went from the simple loss of pigment all the way up to life -threatening malignancies and back down to common warts.

It's just amazing how much the skin can tell us about what's going on.

Not just on the surface, but deeper inside the body.

It really is.

If there is one final provocative thought I'd want listeners to walk away with, it's that idea of the skin as a window to systemic health.

A velvety patch on the back of the neck isn't just a skin problem.

It could be an alarm for diabetes or even stomach cancer.

A blister on the elbow isn't just a friction rub.

It could be your gut reacting to gluten.

Exactly.

A painful rash on the shins could be a sign of a strep infection somewhere else.

It's a reminder of the importance of looking closely.

It really emphasizes that.

Don't just see the rash.

See the patient attached to it.

You have to.

Don't just skim the surface.

Well, on that note, we are going to wrap up this deep dive into skin pathology.

We hope this helps you visualize these conditions and their mechanisms a little more clearly.

It was a pleasure walking through it.

Thanks for listening, and a huge thank you from the entire last -minute lecture team.

Good luck with your studies.

See you next time.